Nutriband Inc. (NTRB): Price and Financial Metrics

Nutriband Inc. (NTRB): $4.41

0.08 (+1.85%)

POWR Rating

Component Grades








Add NTRB to Watchlist
Sign Up

NTRB Price/Volume Stats

Current price $4.41 52-week high $5.93
Prev. close $4.33 52-week low $1.53
Day low $4.20 Volume 27,000
Day high $4.44 Avg. volume 39,954
50-day MA $2.99 Dividend yield N/A
200-day MA $2.86 Market Cap 34.54M

NTRB Stock Price Chart Interactive Chart >

Nutriband Inc. (NTRB) Company Bio

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida

NTRB Latest News Stream

Event/Time News Detail
Loading, please wait...

NTRB Latest Social Stream

Loading social stream, please wait...

View Full NTRB Social Stream

Latest NTRB News From Around the Web

Below are the latest news stories about NUTRIBAND INC that investors may wish to consider to help them evaluate NTRB as an investment opportunity.

NTRB Stock Earnings: Nutriband Reported Results for Q3 2023

Nutriband just reported results for the third quarter of 2023.

InvestorPlace Earnings on InvestorPlace | December 18, 2023

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

ORLANDO, FL / ACCESSWIRE / November 28, 2023 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of its new Heating and Cooling Kinesiology Tape as part of its Active Intelligence ...

Yahoo | November 28, 2023

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

ORLANDO, FL / ACCESSWIRE / November 8, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has signed a supplier agreement with market leading kinesiology tape company, KT Tape. Nutriband Inc.'s wholly owned contract manufacturing ...

Yahoo | November 8, 2023

Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

ORLANDO, FL / ACCESSWIRE / October 11, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has completed the market assessment and commercialization strategy ...

Yahoo | October 11, 2023

Nutriband Unveils Groundbreaking Innovation in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety

Yahoo | September 20, 2023

Read More 'NTRB' Stories Here

NTRB Price Returns

1-mo 80.00%
3-mo N/A
6-mo 86.08%
1-year 32.04%
3-year N/A
5-year -88.98%
YTD 90.09%
2023 -35.64%
2022 -64.24%
2021 -32.80%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!